Endo shareholders will get $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will ...
5d
MyChesCo on MSNMallinckrodt and Endo Announce Merger to Build Diversified Pharmaceuticals PowerhousePharmaceutical leaders Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have entered an agreement to merge, creating a global, ...
Two companies forced to file for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – have agreed to join forces via a $6.7 billion merger. According to the ...
6d
Dealbreaker on MSNPharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock DealWhen the deal closes, Endo will become a wholly owned subsidiary of Mallinckrodt. The combined company will take on a ...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Endo, Inc. (OTC: NDOI) and Mallinckrodt plc.
Wachtell Lipton Rosen & Katz and Davis Polk & Wardwell have scored lead roles on the $6.7bn merger of drugmakers Mallinckrodt and Endo. Wachtell is serving as lead counsel for Dublin-based ...
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal ... Read more about Endo locking into a merger agreement in the Philadelphia Business Journal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results